CDC Repeatedly Advised People With Post-JAB Conditions To Get More Doses

In one example, CISA was presented with records showing a 63-year-old woman experienced chronic kidney disease, with symptoms including kidney swelling, after receiving a second dose of Pfizer’s COVID-19 vaccine.

CISA subject matter experts (SMEs) said that the diagnosis could not be definitively confirmed without a kidney biopsy but that they still felt comfortable using a causality algorithm for the presumed diagnosis developed in part by Dr. Kathryn Edwards, CISA’s principal investigator.

Applying the algorithm to the case resulted in an “indeterminate” designation, or an inability to rule out the vaccine causing the problem, in part because there was no evidence of other causes. But that inability did not stop the program from recommending additional shots.

“Weighing the potential risks of COVID-19 vaccination and the benefits of preventing COVID-19, the SMEs provided their opinion that the patient should receive future COVID-19 vaccinations,” the Feb. 24, 2023, letter to the patient’s doctor stated.

At the time, the effectiveness of the vaccines against symptomatic infection had been shown to start low and wane quickly, while protection against severe disease began higher but also rapidly dropped.

After the woman received her next shot, the CISA experts said, the doctor should check in on her to see if she experienced recurrent hematuria, or blood in her urine.

“Although the CDC’s subject matter experts claim to have no idea if inflammation of the kidneys in a 63-year-old woman was caused by the mRNA COVID-19 biological, they tell the attending physician to go ahead and give the woman another COVID shot. That amounts to a challenge/re-challenge experiment on a sick woman without informed consent,” Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center, told The Epoch Times in an email.

“Government officials admitting ignorance about a biological product’s potential side effects but directing a doctor to risk a patient’s life by continuing to inject the product into a patient, who already has suffered an injury following use of that product, is immoral,” she added. “We expect and deserve government health officials to adhere to a higher professional and ethical standard of care.”

Some people who experience a problem after a dose of a COVID-19 vaccine have experienced a recurrence of the problem following another dose, according to case studies and surveillance data.

Dr. Edwards, until recently of Vanderbilt University Medical Center, and the CDC did not respond to requests for comment.

Other Letters

The Epoch Times obtained, through the Freedom of Information Act, letters sent by CISA to physicians.

CISA features experts with the CDC and other institutions, including Vanderbilt University, Boston Medical Center, and Johns Hopkins University collaborating to respond to doctors who ask the program to review patient cases and provide recommendations.

“CISA provides consultations for U.S. healthcare providers with complex vaccine safety questions about their patients and conducts vaccine safety clinical research,” the CDC states on its website.

The first COVID-19 vaccines were authorized and recommended in December 2020. From Dec. 1, 2020, through June 1, 2023, CISA provided 48 recommendations to doctors dealing with COVID-19 vaccines, the records show.

In 39.5 percent of the cases, CISA recommended another vaccination. In 23 percent of the cases, CISA recommended against another vaccination. In 14.5 percent of the cases, CISA said there were no reasons patients could not receive more doses. In the remaining cases, CISA advised reassessing the matter down the road or advising a patient who had not yet received a vaccine to receive a vaccine.

The recommendations for future doses came even in cases where CISA was unable to say the vaccine did not cause the adverse event.

In a letter dated May 4, 2021, CISA experts said there was “no evidence” to support non-vaccine causes for the patient’s condition but that there was “no definitive known association” between the condition and Pfizer’s vaccine, leading to an indeterminate designation in the causality algorithm.

While one of the experts said that in a person “with the right immunologic makeup,” the vaccine “could be an initial inciting injury” causing the condition, many of the experts advised the patient to receive another dose.

The patient might want to receive Johnson & Johnson’s vaccine, which uses different technology than the Pfizer and Moderna messenger RNA shots, CISA said in the letter. “Support for this guidance included that it would avoid the lipid envelope and the mRNA presentation of the antigen to this patient,” they wrote.

In another letter, dated Jan. 18, 2022, CISA experts also found no evidence for non-vaccine causes for the patient’s condition, which appeared after Pfizer vaccination. But they repeated the claim that there was no definitive association between the vaccine and the condition, leading to an indeterminate designation.

CISA experts “strongly felt that the risk of COVID-19 infection was higher than the potential risk from another dose of vaccine,” according to the letter, and recommended a second Pfizer dose.

In a third letter, dated May 23, 2022, CISA experts said the causality algorithm resulted in an indeterminate designation “due to lack of strong evidence against a causal association.” They described a “very perplexing case” and acknowledged the patient’s condition was “not understood.”

But CISA experts still advised the patient, who suffered an event after a Pfizer dose and had also recovered from COVID-19, to receive another shot.

“This would be especially important in light of the current surge in circulating Omicron variants,” they wrote.

Small Number of Causal Determinations

A small number of cases led to the determination that the vaccination caused an adverse event.

In six instances, CISA experts determined that the event was “consistent with causal association,” or caused by the vaccination, because the condition suffered by each patient was “a known possible adverse event following immunization.”

In all six cases, experts recommended against additional doses while advising the doctors caring for the patients to follow up with the patients to figure out which non-COVID vaccines the patients could safely receive.

CISA experts also advised against additional COVID-19 vaccine doses in five other cases. The designations in those cases were also indeterminate, making the differences between them and those that resulted in recommendations for future doses unclear apart from several involving people who had expressed opposition to receiving more shots.

In seven other cases, CISA experts said there were no contraindications, or no reasons for not receiving at least one additional dose. The CDC has maintained a short list that currently includes just two contraindications for the COVID-19 vaccines—a history of severe allergic shock or a history of a known diagnosed allergy to a component of one of the shots.

Patients with other conditions, such as heart inflammation after COVID-19 vaccination, are generally advised to avoid additional doses, the CDC says in the list. But that is only a “precaution,” not a contraindication.

CISA also advised doctors of nine of the patients to reassess future COVID-19 vaccination down the road and, in two of the cases, told doctors that patients who had not yet received a COVID vaccine could receive one.

Read more here…

(TLB) published this article By Zachary Stieber via The Epoch Times as posted at ZeroHedge

Header featured image (edited) credit:  CDC/The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Ga.(Madalina Vasiliu/The Epoch Times)

Emphasis added by (TLB)

••••

••••

Stay tuned to …